What is a good vasopressor algorithm for managing hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vasopressor Algorithm for Managing Hypotension

Initial Resuscitation and First-Line Vasopressor

Start with adequate fluid resuscitation (minimum 30 mL/kg crystalloid) followed immediately by norepinephrine as the first-line vasopressor, targeting a mean arterial pressure (MAP) of 65 mmHg. 1, 2

Pre-Vasopressor Requirements

  • Administer at least 30 mL/kg of crystalloid fluids for initial volume resuscitation in hypotensive patients 2
  • In life-threatening hypotension with imminent cerebral or coronary ischemia, start norepinephrine concurrently with fluid resuscitation rather than delaying 2
  • Place an arterial catheter as soon as practical for continuous blood pressure monitoring in all patients requiring vasopressors 1, 2
  • Establish central venous access when possible, though norepinephrine can be started peripherally while awaiting central access 2

Norepinephrine Dosing Protocol

  • Initial dose: 0.02 mg/kg/min, titrated up to 0.1-0.2 mg/kg/min to maintain MAP ≥65 mmHg 2
  • Target MAP of 65 mmHg is appropriate for most patients 1, 2
  • Monitor continuously with arterial catheter and assess tissue perfusion using lactate levels, skin perfusion, mental status, and urine output 2

Escalation for Refractory Hypotension

Second-Line Agent: Add Vasopressin

When norepinephrine alone fails to achieve target MAP, add vasopressin at 0.03 units/minute rather than escalating norepinephrine dose further. 1, 3

  • Vasopressin dose: 0.03 units/minute (range 0.01-0.07 units/minute for septic shock) 1, 3
  • Never use vasopressin as monotherapy—it must be added to norepinephrine, not used alone 1
  • Doses higher than 0.03-0.04 units/minute should be reserved for salvage therapy only 1
  • FDA-approved dosing for post-cardiotomy shock: 0.03-0.1 units/minute 3

Third-Line Options

If target MAP remains unachieved despite norepinephrine plus vasopressin:

  • Add epinephrine (0.05-2 mcg/kg/min) as the preferred third agent, particularly when myocardial dysfunction is present 1, 2
  • Add dobutamine (up to 20 mcg/kg/min) if persistent hypoperfusion exists despite adequate vasopressor support, especially with evidence of low cardiac output 1, 2

Agents to Avoid

Dopamine

  • Strongly avoid dopamine except in highly selected patients with low risk of tachyarrhythmias or absolute/relative bradycardia 1, 2
  • Dopamine is associated with higher mortality and more arrhythmias compared to norepinephrine 1, 2
  • Never use low-dose dopamine for renal protection—this provides no benefit and is strongly discouraged 1, 2

Phenylephrine

  • Avoid phenylephrine as first-line therapy—it may raise blood pressure numbers while actually worsening tissue perfusion 1, 2
  • Use phenylephrine only in specific circumstances: when norepinephrine causes serious arrhythmias, when cardiac output is documented to be high with persistent hypotension, or as salvage therapy when all other agents have failed 1, 2

Special Considerations for Trauma Patients

Hemorrhagic Shock Algorithm

In trauma patients with hemorrhagic shock, prioritize restricted volume replacement with permissive hypotension (systolic BP 80-90 mmHg) until bleeding is controlled, adding norepinephrine only if systolic BP falls below 80 mmHg. 4

  • Target systolic arterial pressure of 80-90 mmHg during active hemorrhage (except in traumatic brain injury) 4
  • Use 0.9% sodium chloride or balanced crystalloid solution for initial fluid resuscitation 4
  • Avoid hypotonic solutions like Ringer's lactate in patients with severe head trauma 4
  • Add norepinephrine only when restricted volume replacement fails to achieve target BP and systolic pressure drops below 80 mmHg 4
  • Consider low-dose arginine vasopressin (bolus of 4 IU followed by 0.04 IU/min) to decrease blood product requirements in severe hemorrhagic shock 4

Inotropic Support in Trauma

  • Infuse dobutamine when myocardial dysfunction is present 4

Critical Monitoring and Pitfalls

Essential Monitoring

  • Continuous arterial blood pressure monitoring via arterial catheter 1, 2
  • Assess tissue perfusion markers: lactate levels, skin perfusion, mental status, urine output 2
  • Monitor for signs of excessive vasoconstriction: digital ischemia, decreased urine output, rising lactate, worsening organ dysfunction despite adequate MAP 1

Common Pitfalls to Avoid

  • Do not use vasopressors as a substitute for adequate fluid resuscitation—this causes excessive vasoconstriction and organ ischemia 2
  • Do not titrate to supranormal blood pressure targets—excessive vasoconstriction compromises microcirculatory flow 1
  • Do not increase vasopressin beyond 0.03-0.04 units/minute—add epinephrine instead if additional support is needed 1
  • Avoid restricting colloids due to adverse effects on hemostasis in trauma patients 4

References

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Vasopressor Management in Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.